These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Social support, anxiety and depression after chemotherapy for ovarian cancer: a prospective study. Hipkins J; Whitworth M; Tarrier N; Jayson G Br J Health Psychol; 2004 Nov; 9(Pt 4):569-81. PubMed ID: 15509362 [TBL] [Abstract][Full Text] [Related]
6. Screening for abdominal aortic aneurysms does not increase psychological morbidity. Khaira HS; Herbert LM; Crowson MC Ann R Coll Surg Engl; 1998 Sep; 80(5):341-2. PubMed ID: 9849335 [TBL] [Abstract][Full Text] [Related]
7. Depression, anxiety, and quality of life in patients with epithelial ovarian cancer. Bodurka-Bevers D; Basen-Engquist K; Carmack CL; Fitzgerald MA; Wolf JK; de Moor C; Gershenson DM Gynecol Oncol; 2000 Sep; 78(3 Pt 1):302-8. PubMed ID: 10985884 [TBL] [Abstract][Full Text] [Related]
8. Screening asymptomatic women for ovarian cancer: American College of Preventive Medicine practice policy. Ferrini R Am J Prev Med; 1997; 13(6):444-6. PubMed ID: 9415790 [No Abstract] [Full Text] [Related]
9. Providing psychosocial support for breast cancer patients based on screening for distress within a consultation-liaison service. Söllner W; Maislinger S; König A; Devries A; Lukas P Psychooncology; 2004 Dec; 13(12):893-7. PubMed ID: 15457540 [TBL] [Abstract][Full Text] [Related]
10. Making decisions about screening for ovarian cancer. Mass screening may not prove to be sound public health policy. Bell R BMJ; 2000 Apr; 320(7239):940; author reply 940-1. PubMed ID: 10787261 [No Abstract] [Full Text] [Related]
11. Proteins' promise--progress and challenges in ovarian cancer proteomics. Koehn H; Oehler MK Menopause Int; 2007 Dec; 13(4):148-53. PubMed ID: 18088525 [TBL] [Abstract][Full Text] [Related]
12. [Problem of uterine and ovarian cancer mass screening]. Ohmura M; Oda M Gan To Kagaku Ryoho; 2002 Nov; 29(11):1907-16. PubMed ID: 12465389 [TBL] [Abstract][Full Text] [Related]
14. A controlled study of mental distress and somatic complaints after risk-reducing salpingo-oophorectomy in women at risk for hereditary breast ovarian cancer. Michelsen TM; Dørum A; Dahl AA Gynecol Oncol; 2009 Apr; 113(1):128-33. PubMed ID: 19178933 [TBL] [Abstract][Full Text] [Related]
15. Screening for ovarian cancer: recommendations and rationale. American College of Physicians. Ann Intern Med; 1994 Jul; 121(2):141-2. PubMed ID: 8017728 [No Abstract] [Full Text] [Related]
16. The NIH Consensus Conference on Ovarian Cancer: screening, treatment, and follow-up. Trimble EL Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S1-3. PubMed ID: 7835792 [No Abstract] [Full Text] [Related]
17. Ovarian cancer screening: still waiting for the right answer. Ellwood D Aust N Z J Obstet Gynaecol; 2009 Oct; 49(5):447. PubMed ID: 19780722 [No Abstract] [Full Text] [Related]
18. Screening for ovarian cancer: not worthwhile for most patients. Wong JG; Feussner JR N C Med J; 1993 Sep; 54(9):438-40. PubMed ID: 8232615 [No Abstract] [Full Text] [Related]
19. Knowledge of risk management strategies, and information and risk management preferences of women at increased risk for ovarian cancer. Tiller K; Meiser B; Gould L; Tucker K; Dudding T; Franklin J; Friedlander M; Andrews L Psychooncology; 2005 Apr; 14(4):249-61. PubMed ID: 15386771 [TBL] [Abstract][Full Text] [Related]
20. Blood test for ovarian cancer may be 99% accurate. McBride D ONS Connect; 2008 Jun; 23(6):25. PubMed ID: 18572874 [No Abstract] [Full Text] [Related] [Next] [New Search]